Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis

Pancreatic cancer is an aggressive, solid tumor, with a grave prognosis. Despite surgical treatment in patients with pancreatic cancer, the rate of recurrence is high. In addition, although tumor biomarkers are frequently used to confirm advanced pancreatic cancer, this is not accurate and the bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Uesato, Yasunori, Sasahira, Naoki, Ozaka, Masato, Sasaki, Takashi, Takatsuki, Mitsuhisa, Zembutsu, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332050/
https://www.ncbi.nlm.nih.gov/pubmed/32614932
http://dx.doi.org/10.1371/journal.pone.0235623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332050/
https://www.ncbi.nlm.nih.gov/pubmed/32614932
http://dx.doi.org/10.1371/journal.pone.0235623

Ejemplares similares